Savaria (TSE:SIS) had its price objective boosted by Desjardins from C$18.50 to C$20.00 in a research report issued to clients and investors on Monday, December 18th. Desjardins’ price objective would indicate a potential upside of 6.38% from the stock’s current price. Desjardins also issued estimates for Savaria’s FY2018 earnings at $0.65 EPS and FY2019 earnings at $0.82 EPS.
Separately, National Bank Financial lifted their price objective on shares of Savaria from C$17.00 to C$18.50 and gave the company an “outperform” rating in a report on Wednesday, November 15th.
Savaria (SIS) traded up C$0.02 during mid-day trading on Monday, hitting C$18.80. 88,715 shares of the company were exchanged, compared to its average volume of 101,633. Savaria has a 52-week low of C$10.18 and a 52-week high of C$18.96. The stock has a market cap of $775.51, a PE ratio of 52.22 and a beta of 0.27.
In other news, Director Peter Allen Drutz sold 5,000 shares of Savaria stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of C$17.81, for a total value of C$89,050.00. In the last ninety days, insiders sold 11,000 shares of company stock worth $192,880.
COPYRIGHT VIOLATION WARNING: This story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/13/savaria-sis-given-new-c20-00-price-target-at-desjardins.html.
Savaria Corporation operates in the accessibility industry in Canada, the United States, and internationally. The company operates in two segments, Accessibility and Adapted Vehicles. The Accessibility segment designs, manufactures, distributes, and installs accessibility products, such as stairlifts for straight and curved stairs; vertical and inclined wheelchair lifts; elevators for home and commercial use; and patient lifts.
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.